Other Clinical Trial - Transcatheter Aortic Valve Replacement (TAVR)-Pilot

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The primary purpose of this this randomized interventional study is to determine if increased level of home-based rehabilitation coupled with a pre-TAVR consultation visit in transcatheter aortic valve replacement patients will improve functional status and quality of life and will decrease hospital readmission.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05283356` - Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation	Phase 4
	Recruiting	`NCT06412354` - EasyCrossTM Device-Self-centering Catheter	N/A

NCT number	NCT02723422
Study type	Interventional
Source	New York University School of Medicine
Contact
Status	Withdrawn
Phase	N/A
Start date	January 2017
Completion date	January 2017

Transcatheter Aortic Valve Replacement (TAVR)-Pilot Trial — TAVR-PT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms